Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04996940
Other study ID # 145421a
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 20, 2021
Est. completion date August 15, 2021

Study information

Verified date August 2023
Source University of Kansas Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is a randomized crossover trial. Current menthol smokers will complete a session with each flavor of an electronic cigarette: menthol and tobacco. The objective of this survey is to assess for flavor preference.


Description:

Participants who report typically smoking menthol cigarettes will be invited to complete a session. Participants will undergo overnight tobacco/nicotine abstinence before the visit (eCO<12ppm). Participants will then be randomized 1:1 to e-cigarette flavor order (tobacco e-cigarette, menthol e-cigarette). They will complete a 30-minute ad libitum session with the first product, based on randomization, followed by a 1.5 hour standard washout period, followed by a 30-minute ad libitum vaping session with the second product. Throughout each session, puff topography will be measured via a pressure sensor attached to the e-cigarette device. Participants will complete self-report measures of smoking urges and withdrawal symptoms pre- and post-vaping session. In addition, they will complete measures of subjective vaping experience, perceptions of flavor, product demand, and intentions for future use.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date August 15, 2021
Est. primary completion date August 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - typically smoking menthol cigarettes - Non-Hispanic African American or white/Caucasian, - =21 years old, smoke 5-30 cigarettes per day, - daily cigarette smoker - smoked at current rate for at least 6 months - interested in trying e-cigarettes - not interested in or unable/unwilling to quit cigarette smoking - willing to complete one in-person study visits Exclusion Criteria: - Interested in quitting cigarettes in the next 30 days - use of smoking cessation pharmacotherapy in the past 30 days - use of non-cigarette tobacco products in the past 30 days - use of e-cigarettes >5x in lifetime - use of e-cigarettes =4 of the past 30 days - weight < 110 lbs - uncontrolled hypertension (systolic BP = 180 or diastolic BP = 105) - pregnant, plans to become pregnant, or breastfeeding - live >10 miles from study site (Fairway CRU) - current enrollment is a research study or program that aims to alter tobacco use

Study Design


Related Conditions & MeSH terms


Intervention

Device:
E-cigarette product
Participants will be randomized 1:1 to e-cigarette flavor order either: tobacco e-cigarette menthol e-cigarette

Locations

Country Name City State
United States University of Kansas Medical Center Kansas City Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Kansas Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire Scale "Intentions for Future Use" Using the questionnaire scale "Intentions for Future Use" How much each participant intends to use the products in the future.
Scale: "Think about the product you just used. If this was the only flavor available, how likely would you be to try this flavor again?
Extremely unlikely
Unlikely
Neutral
Likely
Extremely likely The range of observed responses from participants for both groups was 1-5. Not all participants completed all study measures so the number of respondents is lower than enrolled.
during the intervention
Secondary Questionnaire Scale "Subjective Vaping Experience" Please indicate how you are feeling right now on a scale from 0 to 100 where 0 is not at all and 100 is extremely.
How pleasant would the e-cigarette be to use right now? The observed range of responses from participants for both arms was 0 to 100. Not all participants completed all study measures so the number of respondents is lower than enrolled.
during the intervention
Secondary Questionnaire Scale "Perceptions of Flavor" On a scale from 0 to 100 where 0 is not at all and 100 is extremely, to what extent did you like the flavor you just used? The observed range of responses from participants in both arms was from 0 to 100.
Not all participants completed all study measures so the number of respondents is lower than enrolled.
during the intervention
Secondary Questionnaire Scale "Product Demand" On a scale from 0 to 100 where 0 is not at all and 100 is extremely, how willing would you be to use the flavor you just used again in the future? The observed range of responses from participants in both arms was from 0 to 100.
Not all participants completed all study measures so the number of respondents is lower than enrolled.
during the intervention
See also
  Status Clinical Trial Phase
Withdrawn NCT02432066 - Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions Phase 2
Completed NCT03960138 - Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Completed NCT04646668 - Comparative Abuse Liability Among African American and White Smokers N/A
Completed NCT02560324 - Effect of Ramelteon on Smoking Abstinence Phase 2
Completed NCT02347605 - Medicinal Nicotine for Preventing Cue Induced Craving N/A
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Terminated NCT01800500 - Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers N/A
Completed NCT01625767 - Tobacco Approach Avoidance Training for Adolescent Smokers-1 Phase 2
Completed NCT01428310 - Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke Phase 1
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT00967005 - N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers Phase 2
Completed NCT01337817 - A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers Phase 1
Active, not recruiting NCT00751660 - Screening Methods in Finding Lung Cancer Early in Current or Former Smokers N/A
Completed NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking N/A
Completed NCT00664261 - Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking N/A
Completed NCT00134927 - A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches N/A
Completed NCT00158158 - Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2 Phase 2/Phase 3
Completed NCT00158145 - Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2 Phase 2